Heidelberg Pharma AG / DE000A11QVV0

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Prof. Dr.
First name:	Andreas
Last name(s):	Pahl

2. Reason for the notification

a) Position / status

Position:

Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A11QVV0

b) Nature of the transaction

Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for employees and members of the Management Board of Heidelberg Pharma AG.

Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)

Price(s)	Volume(s)
1.89 EUR	170,100.00 EUR

d) Aggregated information

Price	Aggregated volume
1.8900 EUR	170,100.0000 EUR

e) Date of the transaction

23/07/2025; UTC+2

f) Place of the transaction

Outside a trading venue